Dna Sequencing Market Size to grow by USD 17344.5 million between 2024-2028
According to a research report “ Dna Sequencing Market” by End-user (Academic research, Clinical research, Hospitals and clinics, Pharmaceutical and biotechnology companies) Solution (Products, Services) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 17344.5 million, at a CAGR of 20.01% during the forecast period. Next-generation sequencing (NGS) technology, a game-changer in DNA sequencing, enables the massively parallel processing of an entire human genome within a day, revolutionizing genomic research. With the International Agency for Research on Cancer (IARC) projecting 27.5 million new cancer cases and 16.3 million cancer deaths by 2040, the increasing prevalence and incidence of cancer in various countries, including India, necessitate the adoption of NGS for precise diagnosis and effective treatment. This growing demand for NGS in cancer diagnosis and treatment is propelling the global DNA sequencing market forward..
Browse market data tables, figures, and in-depth TOC on “Dna Sequencing Market” by End-user (Academic research, Clinical research, Hospitals and clinics, Pharmaceutical and biotechnology companies) Solution (Products, Services) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By End-user, the Academic research segment is projected to dominate the market size in 2024
The DNA sequencing market is experiencing significant growth due to the increasing demand for genetic research and personalized medicine. Advanced technologies, such as next-generation sequencing, are driving innovation and efficiency in the industry. Market leaders are focusing on developing cost-effective solutions and expanding their product portfolios to cater to diverse applications. The market is expected to continue its robust expansion in the coming years.
By Solution, Products segment is expected to hold the largest market size for the year 2024
The DNA sequencing market is experiencing significant growth due to the increasing demand for genetic research and personalized medicine. Companies are investing heavily in advanced technologies, such as next-generation sequencing, to streamline the process and reduce costs. The market is expected to reach substantial growth in the coming years, driven by collaborations, acquisitions, and technological innovations. Businesses are leveraging DNA sequencing to gain a competitive edge in the healthcare and biotech industries.
North America is forecasted to hold the largest market size by region in 2024
The DNA sequencing market is experiencing significant growth due to the increasing demand for genetic research and personalized medicine. Advanced technologies, such as next-generation sequencing, are driving innovation and efficiency in the industry. Market leaders are investing heavily in R&D to improve accuracy and reduce costs, making DNA sequencing more accessible to researchers and healthcare providers. This trend is expected to continue, with the global market projected to reach USD25.5 billion by 2025.
The Dna Sequencing Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
The DNA sequencing market is experiencing significant growth due to the increasing demand for high-throughput sequencing technologies in various industries, including clinical diagnostic laboratories, reproductive health, forensics, drug discovery, and personalized medicine. Benchtop sequencers are becoming increasingly popular due to their smaller footprint and faster sequencing speed. Clinical diagnostic laboratories are leveraging genomic data to provide precise clinical diagnosis, particularly in the fields of reproductive health and oncology. Reproductive health applications include prenatal and newborn screening, while oncology applications involve identifying DNA variations for cancer diagnosis and treatment. The clinical diagnosis segment is expected to dominate the DNA sequencing market due to the growing need for genetic information in healthcare. The consumables segment is also expected to grow significantly due to the increasing demand for sequencing platforms and the need for bioinformatics tools for analyzing genomic data. Next-Generation Sequencing (NGS) technologies, such as Whole-Genome Sequencing (WGS), are revolutionizing the field of genomics by enabling the analysis of gene expression, genetic variation, and pharmacogenomics. NGS is also being used in precision medicine and cancer research to develop personalized treatment plans based on individual genetic information. The DNA sequencing market is expected to continue growing as healthcare frameworks embrace the potential of genomics in clinical diagnosis and drug discovery. The market is expected to reach significant growth in the coming years, driven by the increasing demand for faster, more accurate, and cost-effective sequencing technologies.
Market Research Overview
The DNA sequencing market is a rapidly growing sector within the biopharmaceutical industry, encompassing diagnostics, research labs, and clinical diagnostic laboratories. This market includes various segments such as instruments, consumables (including nucleotides), and skilled professionals. High-throughput sequencing technologies, like benchtop sequencers and Next-Generation Sequencing (NGS), are transforming fields like reproductive health, forensics, biomarker discovery, personalized medicine, drug discovery, epidemiology, metagenomics, immune system monitoring, and agrigenomics. Pre-sequencing processes, such as library preparation, are essential for generating accurate genomic data. Advancements in Nanopore Sequencing, resequencing, targeted sequencing (Whole Exome Sequencing, Whole Genome Sequencing), and Sanger Sequencing continue to drive innovation. The scientific community is leveraging machine learning and artificial intelligence for tertiary analysis of genomic data. Clinicians and researchers rely on this genetic information for clinical testing procedures, consumer genomics, academic research, and clinical research. Sequencing speed and healthcare frameworks are crucial considerations in the DNA sequencing market. Applications in oncology, pharmacogenomics, gene expression, genetic variation, precision medicine, and cancer research are fueling market growth. The Consumables segment, including sequencing platforms and bioinformatics, is a significant contributor to the market's expansion.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
